Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mcgeoch, P.
Right arrow Articles by Butler, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mcgeoch, P.
Right arrow Articles by Butler, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 1999; 38: 905-906
© 1999 British Society for Rheumatology

Letters to the Editor

The ARC steroid trial and its effect on clinical practice

P. Mcgeoch1 and R. Butler

Department of Rheumatology, Robert Jones & Agnes Hunt Orthopaedic Hospital, Oswestry, Shropshire SY10 7AG, UK

Correspondence to: R. Butler, Department of Rheumatology, Robert Jones & Agnes Hunt Orthopaedic Hospital, Oswestry, Shropshire SY10 7AG, UK.

SIR, We read the recent article from the ARC low-dose glucocorticoid study group [1] on the effect of steroid withdrawal after 2 yr treatment in early RA with interest. The previous paper by Kirwan et al. [2] was widely publicized by the ARC in July 1995 and this included sending . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
M. Byron
The ARC steroid trial and its effects on clinical practice
Rheumatology, March 1, 2000; 39(3): 340 - 340.
[Full Text] [PDF]